ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 30 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,000 | -66.7% | 2,500 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | -25.0% | 2,500 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | +33.3% | 2,500 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 2,500 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 2,500 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -37.5% | 2,500 | 0.0% | 0.00% | – |
| Q4 2015 | $8,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 8,147,650 | $2,864,000 | 0.84% |
| Consonance Capital Management LP | 37,000,000 | $13,006,000 | 0.78% |
| CVI Holdings, LLC | 2,850,477 | $1,002,000 | 0.37% |
| SABBY MANAGEMENT, LLC | 972,285 | $342,000 | 0.07% |
| J. Goldman & Co LP | 2,150,385 | $756,000 | 0.05% |
| Virtu Financial LLC | 668,600 | $235,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 130,000 | $46,000 | 0.01% |
| Summit X, LLC | 68,200 | $24,000 | 0.01% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 107,200 | $38,000 | 0.01% |
| Laidlaw Wealth Management LLC | 28,000 | $10,000 | 0.01% |